批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2018/03/19 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2002/02/20 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/10/17 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/03/06 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1997/02/10 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1996/12/31 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1996/12/10 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1995/05/08 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1991/12/30 |
SUPPL-6(补充) |
Approval |
Labeling |
|
|
|
1988/12/05 |
SUPPL-5(补充) |
Approval |
Labeling |
|
|
|
1983/03/14 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1981/08/20 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1980/12/30 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1980/06/27 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1980/04/10 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:TRIFLURIDINE 剂型/给药途径:SOLUTION/DROPS;OPHTHALMIC 规格:1% 治疗等效代码:AT
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
018299 |
001 |
NDA |
VIROPTIC |
TRIFLURIDINE |
SOLUTION/DROPS;OPHTHALMIC |
1% |
Prescription |
Yes |
Yes |
AT |
Approved Prior to Jan 1, 1982
|
MONARCH PHARMS |
074311 |
001 |
ANDA |
TRIFLURIDINE |
TRIFLURIDINE |
SOLUTION/DROPS;OPHTHALMIC |
1% |
Prescription |
No |
No |
AT |
1995/10/06
|
SANDOZ |
205438 |
001 |
ANDA |
TRIFLURIDINE |
TRIFLURIDINE |
SOLUTION/DROPS;OPHTHALMIC |
1% |
Discontinued |
No |
No |
AT |
2017/07/28
|
HIKMA |